Pfizer Public Policy: Pricing and Value
Pharmaceutical innovation is one of society's best hopes for curbing the cost of illness and extending the length and quality of life. Explore this section to learn about Pfizer's views of the value that prescription drugs offer and why it is critical for countries to maintain public policies that encourage investment in the development of new treatments and cures.
In This Section
Drug Spending and Utilization
Pfizer believes medicines are one of the best values in health care-both for patients and health care payers. Find out why.
Research and Development
Pfizer invests more in pharmaceutical research than any other private institution in the world. Learn more about Pfizer's commitment to drug discovery and development.
Clinical Trials
Learn about the importance of clinical trials to developing new prescription drugs and Pfizer's policies on clinical trials.
Intellectual Property
Understand why Pfizer believes it is in the best interest of patients to enforce the strong intellectual property rights of the U.S. system.
Price Controls
Learn about why Pfizer believes that price controls are not a good solution to patients' access concerns.
Importation
Some groups are suggesting that the U.S. should import pharmaceuticals from other countries. Find out why Pfizer believes importation would not be in the best interest of patients.
Generics
Pfizer believes that generic drugs play an important role in the health care system and should be used when appropriate. Learn why Pfizer believes the intellectual property rights of innovator companies are also important and should be protected.
Last Updated September 2007
Learn more about our commitments and performance in the area of corporate responsibility.
Learn more about our progress in building a foundation for solid, sustainable growth and
our promise to continue
as a leader in meeting
one of the world's most basic needs: better health care for more people.

